Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century

@article{ivljak2014CouldCB,
  title={Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century},
  author={Rok {\vC}ivljak and Maddalena Giannella and Stefano Di Bella and Nicola Petrosillo},
  journal={Expert Review of Anti-infective Therapy},
  year={2014},
  volume={12},
  pages={249 - 264}
}
The widespread use of antibiotics has been associated with the emergence of antimicrobial resistance among bacteria. ‘ESKAPE’ (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acintobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) pathogens play a major role in the rapidly changing scenario of antimicrobial resistance in the 21st century. Chloramphenicol is a broad spectrum antibiotic that was abandoned in developed countries due to its association with fatal… Expand
Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
TLDR
The combination CST/CHL showed a synergistic effect and enhanced bacterial killing in the four tested strains and significantly delayed re-growth and suppressed the emergence of CST resistance. Expand
Chloramphenicol Resurrected: A Journey from Antibiotic Resistance in Eye Infections to Biofilm and Ocular Microbiota.
TLDR
Chloramphenicol seems suitable to be used as topical eye formulation for the limited rate of resistance compared to fluoroquinolones, for its scarce induction of bacterial resistance and antibiofilm activity, and for the hypothetical low impact on ocular microbiota disturbance. Expand
Chloramphenicol use and susceptibility patterns in Israel: a national survey.
TLDR
The susceptibility of bacteria to chloramphenicol is assessed in Israeli hospitals as influenced by infectious disease specialists' attitudes with regard to its potential harms, with high susceptibility rates found among gram-positive, gram-negative and anaerobic bacteria. Expand
Synergistic Microbicidal Effect of Auranofin and Antibiotics Against Planktonic and Biofilm-Encased S. aureus and E. faecalis
TLDR
A combination of auranofin with linezolid, fosfomycin, and chloramphenicol can provide a synergistic microbicidal effect in vitro and in vivo, which rapidly enhances antimicrobial activity and may help prevent or delay the emergence of resistance. Expand
Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol.
TLDR
The combination of polymyxin B and chloramphenicol used against NDM-producing MDR K. pneumoniae substantially enhanced bacterial killing and suppressed the emergence of poly myxin resistance. Expand
β-Lactam and chloramphenicol-resistant enterobacteria in hospital surfaces
TLDR
The following study aimed to research the Enterobacteriaceae present on the material surfaces of a hospital environment in a Community Health Unit in Ceara-Brazil, for enteric bacteria resistant to drugs were found in two environments in the facility. Expand
Octapeptin C4 Induces Less Resistance and Novel Mutations in an Epidemic Carbapenemase-producing Klebsiella pneumoniae ST258 Clinical Isolate Compared to Polymyxins
TLDR
Comparing and contrast the acquisition of XDR Klebsiella pneumoniae resistance in vitro with all three lipopeptides reveals a differing mode of action compared to polymyxin resistance, which provides hope for future therapeutics to combat the increasingly threat ofXDR bacteria. Expand
A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India
TLDR
Colistin resistance among Gram-negative bacteria, especially K. pneumoniae, is emerging in Indian hospitals and fosfomycin, tigecycline, and chloramphenicol may be options for combination therapy. Expand
Therapeutic Options for Infections due to vanB Genotype Vancomycin-Resistant Enterococci.
TLDR
The aim of this article is to discuss the pathogenesis of infections due to enterococci harboring the vanB operon (vanBVRE) and their therapeutic, state-of-the-art, and future treatment options and provide a comprehensive and easy to use review for clinical purposes. Expand
Synergistic Antibiotic Combinations
TLDR
Because combination therapy will continue to be used in the absence of supportive clinical data, it will be important in the future to investigate mechanistic principles that may lead to predictive models for successful patient outcomes. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 171 REFERENCES
Is chloramphenicol making a comeback?
TLDR
In an era of increasing resistance to many antibiotic preparations, chloramphenicol might have a role in the treatment of intraabdominal and respiratory tract infections. Expand
Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
  • H. Maltezou
  • Biology, Medicine
  • International journal of antimicrobial agents
  • 2009
TLDR
In vitro studies reveal that tigecycline and colistin are the only antibacterial agents with consistent activity against MBL-producing strains, and MBL inhibitors are urgently needed, however, none is in late pre-clinical development. Expand
Factors associated with antimicrobial resistance among clinical isolates of Klebsiella pneumoniae: 1-year survey in a French university hospital
TLDR
Results suggest a link between adhesion capabilities and resistance to certain antibiotics and indicate that strains with a high mutagenesis capacity are more likely to acquire antibiotic resistance genes. Expand
The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.
TLDR
Although chloramphenicol was well-tolerated, no significant effect of its use on mortality could be demonstrated and it was concluded that it should not be used in the treatment of VRE patients. Expand
Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China.
TLDR
Investigation of extended-spectrum beta-lactamases in China confirmed that ESBL producers are common among hospital strains of Escherichia coli and Klebsiellae pneumoniae in China and it is important to monitor such strains closely and prevent their spread. Expand
[Antibiotics resistance of meticilline-resistant Staphylococcus aureus: detection of the first glycopeptides low sensibility strains in Tunisia].
TLDR
Two methicillin-resistant Staphylococcus aureus strains isolated in the F. Bourguiba hospital of Monastir (Tunisia) are identified, showing reduced susceptibility to glycopeptides susceptibility, which is the first reported MRSA showing reduced susceptible to glycopesptides in Tunisia. Expand
Multiresistant Gram-negative infections: a global perspective
TLDR
Clinicians need to be aware of the rising problem of resistance in nosocomial and community-acquired Gram-negative pathogens and novel agents are urgently needed to combat these infections and innovative infection control strategies need to been devised to protect vulnerable patients. Expand
[Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics].
TLDR
The mode of action of chloramphenicol against the three most common meningeal pathogens after the newborn period was reevaluated and was found to be bactericidal against H. influenzae, Streptococcus pneumoniae and Neisseria meningitidis. Expand
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.
  • L. Rice
  • Medicine
  • The Journal of infectious diseases
  • 2008
TLDR
The research agenda of the National Institute of Allergy and Infectious Diseases (NIAID) for antimicrobial resistance is detailed, indicating that NIAID funding of antimicrobial research has grown considerably over the past decade, now totaling more than $800 million annually. Expand
[Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics].
TLDR
The mode of action of chloramphenicol against the three most common meningeal pathogens after the newborn period was reevaluated and bactericidal action against H. influenzae, Streptococcus pneumoniae and Neisseria meningitidis was found. Expand
...
1
2
3
4
5
...